首页> 外国专利> method of obtaining biologically active substance from bovine spleen and pharmaceutical composition on the basis u0438u043cu043cu0443u043du043eu043cu043eu0434u0435u043bu0438u0440u0443u044eu0449u0435u0439, u0430u043du0442u0438u0433u0438 u043fu043eu043au0441u0438u0447u0435u0441u043au043eu0439 and conversion activity

method of obtaining biologically active substance from bovine spleen and pharmaceutical composition on the basis u0438u043cu043cu0443u043du043eu043cu043eu0434u0435u043bu0438u0440u0443u044eu0449u0435u0439, u0430u043du0442u0438u0433u0438 u043fu043eu043au0441u0438u0447u0435u0441u043au043eu0439 and conversion activity

机译:u0438 u043c u043c u0443 u043d u043e u043c u043e u0434 u0435 u0435 u043b u0438 u0440 u0443 u0433 u043e u043 u0439, u0430 u043d u0442 u0438 u0433 u0438 u043f u043e u043a u0441 u0438 u0447 u0435 u0441 u043a u043e u0439和转换活动

摘要

task of the invention is the improved specific activity and output of the target product.method includes shredding the spleen of embryos of animal, the impact on her u044du043au0441u0442u0440u0430u0433u0438u0440u0443u044eu0449u0438u043c agent, the extract and the subsequent removal of u044du043au0441u0442u0440u0430u0433u0438u0440u0443u044eu0449u0435 the agentas a u044du043au0441u0442u0440u0430u0433u0438u0440u0443u044eu0449u0435u0433u043e agent use 0.9% solution of sodium chloride, the impact u044du043au0441u0442u0440u0430u0433u0438u0440u0443u044eu0449u0438u043c agent will have.and the extract are by ultra to u0443u043bu044cu0442u0440u0430u0444u0438u043bu044cu0442u0440u0430u0446u0438u043eu043du043du044bu0445 installations with the consistent application of membranes.with the term of detention on the molecular weight of 50 000 and 5 000, then to add to u0434u0438u0430u043bu0438u0437u0430u0442u0443 preservative - u043fu0430u0440u0430u043eu043au0441u0438u0431u0435u043du0437u043eu0439u043du043eu0439 acid methyl ester s and collect the target product.the pharmaceutical composition contains, as an active ingredient u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 effective amount of the drug is a substance obtained in accordance with p.1 formula and a preservative - u043fu0430u0440u0430u043eu043au0441u0438u0431u0435u043du0437u043eu0439u043du043eu0439 acid methyl ester with the following components: methyl ester u043fu0430u0440u0430u043eu043au0441u0438u0431u0435u043du0437u043eu0439u043du043eu0439 acid ratio is 0.07 g, herbal t - substance to 100 ml.
机译:本发明的任务是提高目标产物的比活性和产量。该方法包括切碎动物胚胎的脾脏,对其动物的影响。 u044e u0449 u0438 u043c代理,提取并随后移除 u044d u043a u0431 u0441 u0442 u0440 u0430 u0433 u0438 u0440 u0443 u044e u0449 u0435代理为 u044d u043a u0441 u0442 u0440 u0430 u0433 u0438 u0440 u0443 u044e u0449 u0435 u0433 u043e剂使用0.9%的氯化钠溶液,影响 u044d u043a u0441 u0441 u0442 u0440 u0430 u0433 u0438 u0440 u0443 u044e u0449 u0438 u043c代理程序将被提取,并且提取到的是 u0443 u043b u044c u0442 u0440 u0430 u0444 u0438 u043b u044b u044c u0442 u0440 u0430 u0446 u0438 u043e u043d u043d u044b u04b的安装与膜的应用一致。保留期的分子量分别为50000和5000,然后加到 u0434 u0438 u0430 u043b u0438 u0437 u0430 u0442 u0443 preser阴性- u043f u0430 u0440 u0430 u043e u043a u0441 u0438 u0431 u0435 u043d u0437 u043e u0439 u043d u043d u043e u0439酸性甲酯并收集目标产物。药物组合物包含,作为有效成分 u0442 u0435 u0440 u0430 u043f u0435 u0432 u0442 u0438 u0447 u0435 u0441 u043a u0438是根据p.1公式获得的物质,防腐剂- u043f u0430 u0440 u0430 u043e u043a u0441 u0438 u0431 u0435 u043d u0437 u043e u0439 u043d u043e u0439具有以下成分的酸性甲酯:甲酯 u043f u0430 u0440 u0430 u043e u043a u0441 u0438 u0431 u0435 u043d u0437 u043e u0439 u043d u043e u0439酸比为0.07 g,草药t物质为100毫升。

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号